The Second Affiliated Hospital, Zhejiang University School of Medicine
The Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China10 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy | Cranial Nerve Injuries, Craniocerebral Trauma, cranial nerve neuropathy, eye disorder, glaucoma, injury, nervous system disorder, nervous system injury, ocular hypertension, open-angle glaucoma, optic nerve disorder, traumatic optic neuropathy | Recruiting | Phase 2 | 2026-08-24 | NCT07777861 | |
| Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS | Respiration Disorders, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder | Recruiting | Not stated | 2026-07-27 | NCT07726940 | |
| Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2026-05-22 | NCT06551220 | |
| Comparison of Radiofrequency Ablation With Concomitant or Staged Treatment for Tributary Varicose Veins | Varicose Veins of Lower Limb | Not yet recruiting | Not applicable | 2026-03-03 | NCT07445425 | |
| Clinical Study of Oncolytic Vaccinia VIrus Delivering Targeted CD19 in Vivo CAR-T/M Therapy for Refractory/Relapsed B-cell Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2026-02-10 | NCT07398963 | |
| Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence | RFS | Active, not recruiting | Phase 2 | 2026-01-09 | NCT07328828 | |
| Exploration of Sintilimab + Bevacizumab + AG Chemotherapy as First-Line Treatment for Unresectable Advanced/Metastatic Cholangiocarcinoma | ORR,OS,PFS | Not yet recruiting | Phase 2 | 2026-01-09 | NCT07328802 | |
| Left Ventricular Myocardial Work for Predicting Response to CRT | cardiovascular disorder, heart disorder, heart failure | Not yet recruiting | Not stated | 2026-01-06 | NCT07319065 | |
| Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab | Colorectal Cancer Metastatic | Recruiting | Phase 2 | 2025-12-22 | NCT06540326 | |
| Study of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory CLL/SLL | B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-04-16 | NCT04494503 |